Expanding the indication for TAVI: who, why and when?

Operators: D. Tchétché, B. Farah
Chairpersons: P. MacCarthy, O. Wendler
Session coordinator: P. MacCarthy
Control Desks: G.G. Toth, J.A. Oreglia

Learning Objectives

  • To critically evaluate the data to support the use of TAVI in intermediate risk patients
  • To appreciate the outcomes after TAVI and surgical aortic valve replacement in intermediate risk patients
  • To identify new and more challenging patient groups who may now benefit from TAVI